MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer
Background Immune checkpoint inhibitors (ICIs) have had a profound impact on the treatment of many tumors; however, their effectiveness against triple-negative breast cancers (TNBCs) has been limited. One factor limiting responsiveness of TNBCs to ICIs is a lack of functional tumor-infiltrating lymp...
Main Authors: | Song Liu, Qiang Hu, Mark Long, Donald Kufe, Nami Yamashita, Atsushi Fushimi, Masaaki Yamamoto, Tsuyoshi Hata, Masayuki Hagiwara, Atrayee Bhattacharya |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2021-01-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/9/1/e002115.full |
Similar Items
-
Targeting MUC1-C suppresses BCL2A1 in triple-negative breast cancer
by: Hiraki, Masayuki, et al.
Published: (2020) -
MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
by: Yota Yasumizu, et al.
Published: (2020-01-01) -
MUC1-C promotes the suppressive immune microenvironment in non-small cell lung cancer
by: Audrey Bouillez, et al.
Published: (2017-09-01) -
Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
by: Yota Yasumizu, et al.
Published: (2020-02-01) -
MUC1-C integrates type II interferon and chromatin remodeling pathways in immunosuppression of prostate cancer
by: Bhattacharya, A., et al.
Published: (2022)